O
ISSUER//CIK 0001797336
Old Ayala, Inc
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 10-K5.4 MBOld Ayala, IncMar 31, 6:38 AM ET·0001213900-23-024952
- SC 13G/A119.3 KBOld Ayala, IncFeb 8, 5:16 PM ET·0001104659-23-014617
- SC 13G94.4 KBOld Ayala, IncFeb 7, 6:01 AM ET·0001178913-23-000394
- SC 13G/A32.9 KBOld Ayala, IncFeb 6, 2:49 PM ET·0000846087-23-000077
- 8-K236.8 KBOld Ayala, IncJan 25, 4:53 PM ET·0001493152-23-002463
- SC 13G/A111.1 KBOld Ayala, IncJan 23, 4:29 PM ET·0001178913-23-000228
- 8-K201.7 KBAyala Pharmaceuticals, Inc.Jan 13, 4:01 PM ET·0001213900-23-002771
- SC 13G/A111.8 KBAyala Pharmaceuticals, Inc.Jan 9, 6:51 AM ET·0001178913-23-000101
- 8-K285.4 KBAyala Pharmaceuticals, Inc.Jan 4, 5:03 PM ET·0001193125-23-001582
- 8-K151.1 KBAyala Pharmaceuticals, Inc.Nov 23, 4:03 PM ET·0001193125-22-292007
Insiders
10- aMoon Growth Fund Limited Partnership10% Owner
- Bisker-Leib VeredDirector
- Golan RoyChief Financial Officer
- GOLDBERG MURRAY ADirector
- Gordon Gary B.Chief Medical Officer
- Harel Insurance Co LTD10% Owner
- Harel Insurance Investments & Financial Services Ltd.10% Owner
- Israel Biotech Fund I, L.P.10% Owner
- Maimon YossiDirector, CFO, Secretary and Treasurer
- Mamluk RoniDirector, President & CEO
Tickers
No tickers on record
Addresses
business
1313 N. MARKET STREET SUITE 5100
WILMINGTON, DE, 19801
mailing
1313 N. MARKET STREET SUITE 5100
WILMINGTON, DE, 19801
Former Names
- Ayala Pharmaceuticals, Inc.2023-01-19